Terms: = Leukemia AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Clinical Outcome
13 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. B-Lymphoblastic leukemia With Aberrant CD5 Expression.
Ye MT; Zhu J; Luo DX; Wang Y; Chen Z; Yang Y; Tian C; Zhang Y; You MJ
Am J Clin Pathol; 2021 Sep; 156(4):586-595. PubMed ID: 33822875
[TBL] [Abstract] [Full Text] [Related]
3. Eleven-marker 10-color flow cytometric assessment of measurable residual disease for T-cell acute lymphoblastic leukemia using an approach of exclusion.
Tembhare PR; Chatterjee G; Khanka T; Ghogale S; Badrinath Y; Deshpande N; Panda D; Patkar NV; Narula G; Girase K; Verma S; Sanyal M; Sriram HN; Banavali S; Gujral S; Subramanian PG
Cytometry B Clin Cytom; 2021 Jul; 100(4):421-433. PubMed ID: 32812702
[TBL] [Abstract] [Full Text] [Related]
4. FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor.
Das N; Thakral D; Singh G; Malhotra A; Phulware RH; Gogia A; Gupta R
Indian J Pathol Microbiol; 2019; 62(4):614-617. PubMed ID: 31611454
[TBL] [Abstract] [Full Text] [Related]
5. Role of CD81 and CD58 in minimal residual disease detection in pediatric B lymphoblastic leukemia.
Tsitsikov E; Harris MH; Silverman LB; Sallan SE; Weinberg OK
Int J Lab Hematol; 2018 Jun; 40(3):343-351. PubMed ID: 29500862
[TBL] [Abstract] [Full Text] [Related]
6. Blastic plasmacytoid dendritic cell neoplasm: cytopathologic findings.
Zheng G; Schmieg J; Guan H; Ali SZ
Acta Cytol; 2012; 56(2):204-8. PubMed ID: 22378086
[TBL] [Abstract] [Full Text] [Related]
7. [Detecting minimal residual disease status in allogeneic hematopoietic stem cell transplantation of patients with high-risk acute leukemia].
Shi XL; Tang XW; Wei XA; Zhao BR; Zhou QL; Ye F; Lu YX; Sun XW; Zhu MQ; Shen WH; Qiu HY; Sun AN; Wu DP
Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(38):2692-6. PubMed ID: 22321979
[TBL] [Abstract] [Full Text] [Related]
8. Acute myelogenous leukemia with t(6;9)(p23;q34) and marrow basophilia: an overview.
Chi Y; Lindgren V; Quigley S; Gaitonde S
Arch Pathol Lab Med; 2008 Nov; 132(11):1835-7. PubMed ID: 18976025
[TBL] [Abstract] [Full Text] [Related]
9. BAALC, a novel marker of human hematopoietic progenitor cells.
Baldus CD; Tanner SM; Kusewitt DF; Liyanarachchi S; Choi C; Caligiuri MA; Bloomfield CD; de la Chapelle A
Exp Hematol; 2003 Nov; 31(11):1051-6. PubMed ID: 14585369
[TBL] [Abstract] [Full Text] [Related]
10. Selective internalization of monoclonal antibodies by B-cell chronic lymphocytic leukaemia cells.
Sieber T; Schoeler D; Ringel F; Pascu M; Schriever F
Br J Haematol; 2003 May; 121(3):458-61. PubMed ID: 12716368
[TBL] [Abstract] [Full Text] [Related]
11. cd45RO expression on peripheral lymphocytes as a prognostic marker for adult T-cell leukemia.
Suzuki M; Matsuoka H; Yamashita K; Maeda K; Kawano K; Uno H; Tsubouchi H
Leuk Lymphoma; 1998 Feb; 28(5-6):583-90. PubMed ID: 9613989
[TBL] [Abstract] [Full Text] [Related]
12. Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia.
Escribano L; Orfao A; Villarrubia J; MartÃn F; Madruga JI; Cuevas M; Velasco JL; Rios A; San Miguel JF
Cytometry; 1997 Apr; 30(2):98-102. PubMed ID: 9149916
[TBL] [Abstract] [Full Text] [Related]
13. Immunophenotype of blast cells in acute myeloid leukemia may be a useful predictive factor for outcome.
Tucker J; Dorey E; Gregory WM; Simpson AP; Amess JA; Lister TA; Horton MA
Hematol Oncol; 1990; 8(1):47-58. PubMed ID: 2404842
[TBL] [Abstract] [Full Text] [Related]
